Literature DB >> 10530062

Seroprevalence of cytomegalovirus infection among children and females in Ankara, Turkey, 1995.

S Hizel1, S Parker, U Onde.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is the most frequent known cause of congenital viral infections in humans. Cytomegalovirus is endemic throughout the world, affecting most of the population where the seroprevalence of CMV IgG is known to vary among countries.
METHODS: The present study was designed to show the prevalence of CMV antibodies among children aged 1 day to 15 years and women of child-bearing age in Ankara, Turkey. Antibodies to CMV were analyzed in serum samples of 318 children and 745 women using a passive particle-agglutination test.
RESULTS: The overall prevalence of CMV antibodies was 90.6% among children and 99% among women aged 15-49 years. The difference between stratified age groups was not statistically significant (chi 2 = 4.92, P = 0.177) in either children or females.
CONCLUSIONS: Our findings confirm that CMV is very prevalent in Turkey and is at the higher end of worldwide ranges. Using the results of the present study, the transmission mode of CMV infection and the risk for congenital CMV infection are discussed. We have come to the conclusion that the risk of fetal infection in Turkey cannot be predicted; however, most CMV infections in the first year of life are transmitted from mother to infant and this is the main source of infection in Turkey.

Entities:  

Mesh:

Year:  1999        PMID: 10530062     DOI: 10.1046/j.1442-200x.1999.01118.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  3 in total

1.  Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment.

Authors:  Zeynep Kendi Celebi; Reyhan Calayoglu; Aysun Karasu Yalcı; Serkan Akturk; Sule Sengul; Sim Kutlay; Gokhan Nergizoglu; Sehsuvar Erturk; Neval Duman; Kenan Ates; Kenan Keven
Journal:  Int Urol Nephrol       Date:  2014-09-27       Impact factor: 2.370

2.  Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.

Authors:  Julie H Ishida; Tracy Burgess; Michael A Derby; Pearline A Brown; Mauricio Maia; Rong Deng; Brinda Emu; Becket Feierbach; Ashley E Fouts; X Charlene Liao; Jorge A Tavel
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

3.  High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Craig S Miller; Joseph R Berger; Yunanan Mootoor; Sergei A Avdiushko; Hua Zhu; Richard J Kryscio
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.